Change Language

Select Language

Global Biopharmaceutical Third Party Logistics (3PL) Market to Reach US$ 154.2 Billion by 2027, Propelled by the Exponential Growth in the Pharmaceutical Industries

Published on Nov 16, 2022

The latest report by IMARC, titled “Biopharmaceutical Third Party Logistics (3PL) Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, finds that the global biopharmaceutical third party logistics market size reached US$ 109.6 Billion in 2021. Biopharmaceutical third-party logistics (3PL) refers to the services which are outsourced by pharmaceutical companies through third-party organizations. Its services include receiving small molecule drugs, vaccines, biologics, and other medical products, fulfilling orders, and handling inventory of the goods. In recent years, 3PL has gained momentum, as it helps pharmaceutical and medical therapies, minimizing medicine costs by reducing wasteful overhead expenses, enhancing transportation services, ensuring uninterrupted product supply, and improving the overall efficiencies of the institution.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect effect of the associated industries. These observations will further be integrated into the report.

Global Biopharmaceutical Third Party Logistics Market Trends:

One of the primary factors driving the market is the exponential growth in the pharmaceutical industry. Additionally, the growing trend of outsourcing logistics by numerous medical organizations to optimize their distribution network is creating a positive market outlook. Other than this, the demand for 3PL has exponentially risen on account of the sudden outbreak of the coronavirus disease (COVID-19) to reduce the drug supply disruptions and ensure the availability of critical care drugs. Besides this, numerous technological innovations, such as the introduction of mobile cloud computing, warehouse robotics, real-time monitoring, and data mining solutions, are positively influencing the market growth. The newly introduced technologies assist in automating logistics-related procedures and reducing operation complexities, human errors, and damages that are caused to the products in transit. Moreover, the internet of things (IoT) and near field communication (NFC) based cold chain monitoring products are used to manage temperature-sensitive pharmaceuticals and achieve real-time updates and alerts regarding the shipment. Looking forward, IMARC Group expects the market value to reach US$ 154.2 Billion by 2027, expanding at a CAGR of 5.8% during the forecast period (2022-2027).

Market Summary:

  • Based on the service type, the market has been divided into transportation (air freight and sea freight), warehousing and storage, and others.
  • Region-wise, the market has been segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
  • The competitive landscape of the market has also been analyzed, with some of the key players being Agility Logistics, AmericsourceBergen Corporation, DB Schenker (Deutshe Bahn), DHL International GmbH (Deutsche Post), Fedex Corporation, Kerry Logistics Network Limited, Kuehne+Nagel International AG, Mckesson Corporation, SF Express Co. Ltd., and United Parcel Service of America Inc.
     

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

4